These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 19133120

  • 21. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells.
    Srinivasan S, Koduru S, Kumar R, Venguswamy G, Kyprianou N, Damodaran C.
    Int J Cancer; 2009 Aug 15; 125(4):961-7. PubMed ID: 19384950
    [Abstract] [Full Text] [Related]

  • 22. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.
    Le XF, Arachchige-Don AS, Mao W, Horne MC, Bast RC.
    Mol Cancer Ther; 2007 Nov 15; 6(11):2843-57. PubMed ID: 18025271
    [Abstract] [Full Text] [Related]

  • 23. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I, Roelants FM, Thorner J, Nombela C, Molina M, Cid VJ.
    Biochem J; 2005 Sep 01; 390(Pt 2):613-23. PubMed ID: 15913452
    [Abstract] [Full Text] [Related]

  • 24. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells.
    Papa V, Tazzari PL, Chiarini F, Cappellini A, Ricci F, Billi AM, Evangelisti C, Ottaviani E, Martinelli G, Testoni N, McCubrey JA, Martelli AM.
    Leukemia; 2008 Jan 01; 22(1):147-60. PubMed ID: 17928881
    [Abstract] [Full Text] [Related]

  • 25. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation.
    Okano J, Gaslightwala I, Birnbaum MJ, Rustgi AK, Nakagawa H.
    J Biol Chem; 2000 Oct 06; 275(40):30934-42. PubMed ID: 10908564
    [Abstract] [Full Text] [Related]

  • 26. Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages.
    Jacquel A, Benikhlef N, Paggetti J, Lalaoui N, Guery L, Dufour EK, Ciudad M, Racoeur C, Micheau O, Delva L, Droin N, Solary E.
    Blood; 2009 Oct 22; 114(17):3633-41. PubMed ID: 19721010
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms involved in kinin-induced glioma cells proliferation: the role of ERK1/2 and PI3K/Akt pathways.
    Nicoletti NF, Erig TC, Zanin RF, Pereira TC, Bogo MR, Campos MM, Morrone FB.
    J Neurooncol; 2014 Nov 22; 120(2):235-44. PubMed ID: 25056222
    [Abstract] [Full Text] [Related]

  • 28. Estrogen receptor α induces down-regulation of PTEN through PI3-kinase activation in breast cancer cells.
    Noh EM, Lee YR, Chay KO, Chung EY, Jung SH, Kim JS, Youn HJ.
    Mol Med Rep; 2011 Nov 22; 4(2):215-9. PubMed ID: 21468554
    [Abstract] [Full Text] [Related]

  • 29. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M, Grijalva R, Yu D.
    Cancer Res; 1999 Apr 01; 59(7):1620-5. PubMed ID: 10197638
    [Abstract] [Full Text] [Related]

  • 30. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE.
    Cancer Res; 2010 May 15; 70(10):4151-62. PubMed ID: 20460524
    [Abstract] [Full Text] [Related]

  • 31. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL, Navolanic PM, Steelman LS, Shelton JG, Moye PW, Lee JT, Franklin RA, Mirza A, McMahon M, White MK, McCubrey JA.
    Leukemia; 2003 Jun 15; 17(6):1058-67. PubMed ID: 12764369
    [Abstract] [Full Text] [Related]

  • 32. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro.
    Yan W, Ma X, Zhao X, Zhang S.
    Drug Des Devel Ther; 2018 Jun 15; 12():3961-3972. PubMed ID: 30510404
    [Abstract] [Full Text] [Related]

  • 33. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
    Wang T, Seah S, Loh X, Chan CW, Hartman M, Goh BC, Lee SC.
    Oncotarget; 2016 Jan 19; 7(3):2532-44. PubMed ID: 26565813
    [Abstract] [Full Text] [Related]

  • 34. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.
    Qie S, Chu C, Li W, Wang C, Sang N.
    J Cell Biochem; 2014 Mar 19; 115(3):498-509. PubMed ID: 24122876
    [Abstract] [Full Text] [Related]

  • 35. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R, Palladino C, Nicolosi ML, Lo Presti AR, Malaguarnera R, Ragusa M, Sciortino D, Morrione A, Maggiolini M, Vella V, Belfiore A.
    Oncotarget; 2016 Feb 16; 7(7):7683-700. PubMed ID: 26655502
    [Abstract] [Full Text] [Related]

  • 36. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK, Lee JJ, Yang Y, You KH, Lee JH.
    Carcinogenesis; 2008 Apr 16; 29(4):704-12. PubMed ID: 18258606
    [Abstract] [Full Text] [Related]

  • 37. The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.
    Barbacci EG, Pustilnik LR, Rossi AM, Emerson E, Miller PE, Boscoe BP, Cox ED, Iwata KK, Jani JP, Provoncha K, Kath JC, Liu Z, Moyer JD.
    Cancer Res; 2003 Aug 01; 63(15):4450-9. PubMed ID: 12907618
    [Abstract] [Full Text] [Related]

  • 38. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH, Xue A, Julovi SM, Pavlakis N, Samra JS, Hugh TJ, Gill AJ, Peters L, Baxter RC, Smith RC.
    Clin Cancer Res; 2014 Aug 01; 20(15):4047-58. PubMed ID: 24895459
    [Abstract] [Full Text] [Related]

  • 39. Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells.
    Jang JY, Jeon YK, Kim CW.
    BMC Cancer; 2010 Jul 23; 10():391. PubMed ID: 20650008
    [Abstract] [Full Text] [Related]

  • 40. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
    Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N.
    Cancer Res; 2005 Dec 01; 65(23):11018-25. PubMed ID: 16322251
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.